(NASDAQ: PROK) Prokidney's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.23%.
Prokidney's earnings in 2025 is -$72,474,000.On average, 3 Wall Street analysts forecast PROK's earnings for 2025 to be -$137,341,625, with the lowest PROK earnings forecast at -$147,141,231, and the highest PROK earnings forecast at -$129,484,283. On average, 3 Wall Street analysts forecast PROK's earnings for 2026 to be -$131,455,975, with the lowest PROK earnings forecast at -$153,026,880, and the highest PROK earnings forecast at -$111,827,335.
In 2027, PROK is forecast to generate -$107,413,098 in earnings, with the lowest earnings forecast at -$120,655,809 and the highest earnings forecast at -$94,170,388.